Description
– CJC-1295: a GHRH (growth hormone–releasing hormone) analog designed to stimulate the pituitary to release growth hormone, often with a longer-lasting effect.
– Ipamorelin: a GHSR (ghrelin receptor) agonist that also stimulates growth hormone release, but is generally described as more “selective” (it mainly targets GH release rather than strongly activating other pathways like appetite/ACTH as some other GHS peptides do).
What people aim for (in general terms)
Because both can increase pituitary signaling for growth hormone (GH), many users take the combo with goals related to:
– Muscle/lean mass support
– Recovery and training adaptation
– Body composition changes
– IGF‑1 increases
Reviews
There are no reviews yet.